Veracyte Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
25,580.00
29,373.00
33,704.00
31,358.00
31,003.00
22,999
Depreciation, Depletion & Amortization
999.00
1,175.00
2,254.00
3,511.00
3,841.00
3,920
Other Funds
-
-
247.00
-
-
6,209
Funds from Operations
23,447.00
26,687.00
27,515.00
21,573.00
18,472.00
12,870
Changes in Working Capital
4,288.00
945.00
550.00
6,409.00
5,443.00
651
Net Operating Cash Flow
19,159.00
27,632.00
26,965.00
27,982.00
23,915.00
13,521
Capital Expenditures
1,332.00
2,024.00
6,165.00
4,210.00
1,755.00
Sale of Fixed Assets & Businesses
-
-
-
-
440.00
Purchase/Sale of Investments
-
-
533.00
-
-
Net Investing Cash Flow
1,282.00
9,010.00
6,698.00
4,210.00
1,315.00
Issuance/Reduction of Debt, Net
4,877.00
110.00
-
19,164.00
2,315.00
Net Financing Cash Flow
77,659.00
436.00
37,733.00
52,329.00
218.00
Net Change in Cash
57,218.00
36,206.00
4,070.00
20,137.00
25,448.00
Free Cash Flow
20,491.00
29,656.00
33,130.00
32,192.00
25,670.00
Net Assets from Acquisitions
-
6,916.00
-
-
-
Other Sources
50.00
-
-
-
-
Change in Capital Stock
72,782.00
546.00
37,980.00
33,165.00
2,097.00
About Veracyte
View Profile
